Security key
77313F106
ROCKET PHARMACEUTICALS, INC. - Common Stock (RCKT)
CUSIP: 77313F106
Q3 2024 13F Holders as of 30 Sep 2024
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 92,703,462
- Total 13F value
- $1,709,382,927
- Share change
- +1,244,045
- Put/Call ratio
- 33%
- SEC-reported price per share
- $18.47
- Number of holders
- 189
- Value change
- +$19,027,944
- Number of buys
- 94
- Number of sells
- 71
- Shares outstanding
- 109,265,652
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2024
Institutions
189
Top holders
10
RCKT full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2024
Previous quarter: Q2 2024
ROCKET PHARMACEUTICALS, INC. SEC filings
ROCKET PHARMACEUTICALS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 77313F106
Recent filing periods:
Ownership snapshot
Top reported holders of RCKT - ROCKET PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
WELLINGTON MANAGEMENT GRO...
Disclosed value leader
WELLINGTON MANAGEMENT GRO...
Comparable rows
15/15
Latest evidence
30 Jun 2024
13F
Lead comparable stake: 8.4%
Showing 1-6 of 15 holder rows.
Quick read
WELLINGTON MANAGEMENT GROUP LLP leads the comparable SEC ownership view at 8.4%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens WELLINGTON MANAGEMENT GROUP LLP's linked filing trail.
Comparable ownership
Top 5
WELLINGTON MANAGEMENT GROUP LLP
8.4%
BlackRock Finance, Inc.
5.7%
VANGUARD GROUP INC
5.3%
WESTFIELD CAPITAL MANAGEMENT CO LP
4%
MAVERICK CAPITAL LTD
3.6%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| WELLINGTON MANAGEMENT GROUP LLP |
13F
Company
|
8.4%
|
$197,122,652
9,155,720 shares
|
— | 30 Jun 2024 |
| BlackRock Finance, Inc. |
13F
Company
|
5.7%
|
$133,327,260
6,192,627 shares
|
— | 30 Jun 2024 |
| VANGUARD GROUP INC |
13F
Company
|
5.3%
|
$125,058,083
5,808,550 shares
|
— | 30 Jun 2024 |
| WESTFIELD CAPITAL MANAGEMENT CO LP |
13F
Company
|
4%
|
$93,180,161
4,327,922 shares
|
— | 30 Jun 2024 |
| MAVERICK CAPITAL LTD |
13F
Company
|
3.6%
|
$84,576,557
3,928,312 shares
|
— | 30 Jun 2024 |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
Company
|
2.9%
|
$68,239,000
3,169,448 shares
|
— | 30 Jun 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
189
Shares
92,703,462
Rows available
189
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
176
Q3 2024 holders
189
Holder diff
13
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 value | Q3 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend